Natural Product: NPC245650

Natural Product IDNPC245650
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(2E,4E)-N-Isobutyl-6-Oxohepta-2,4-Dienamide
IUPAC Name (2E,4E)-N-(2-methylpropyl)-6-oxohepta-2,4-dienamide
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL556470
PubChem CID 25195169
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0000331] Fatty amides
          • [CHEMONTID:0001096] N-acyl amines

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WOZPVGYGEASHHK-YDFGWWAZSA-N
Standard InCHI InChI=1S/C11H17NO2/c1-9(2)8-12-11(14)7-5-4-6-10(3)13/h4-7,9H,8H2,1-3H3,(H,12,14)/b6-4+,7-5+
SMILES CC(CN=C(/C=C/C=C/C(=O)C)O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   195.13 Volume:   216.844
?
Van der Waals volume.
Dense:   0.9 LogP:   1.109
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.226
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -1.72
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   4.0
TPSA:   49.66
?
Topological Polar Surface Area.
H-Bond Acceptor:   3.0
H-Bond Donor:   1.0 Rings:   0.0
Heavy Atoms:   3.0

MedChem Properties

QED Drug-Likeness Score:   0.317 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.408 Fsp3:   0.455
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.085 Fluc inhibitor:   0.488
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.014
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.025
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.652 Promiscuous compounds:   0.165

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.538 MDCK Permeability:   -4.587
Pgp-inhibitor:   0.582 Pgp-substrate:   0.47
PAMPA:   0.556
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.026
20% Bioavailability (F20%):   0.322 30% Bioavailability (F30%):   0.829
50% Bioavailability (F50%):   0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.472
Plasma Protein Binding (PPB):   68.105% Volume Distribution (VD):   -0.363
Fu: 30.761%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.987
OATP1B3 inhibitor:   0.961 BCRP inhibitor:   0.01
BSEP inhibitor:   0.954

ADMET: Metabolism

CYP1A2-inhibitor:   0.286 CYP1A2-substrate:   0.922
CYP2C19-inhibitor:   0.888 CYP2C19-substrate:   0.876
CYP2C9-inhibitor:   0.012 CYP2C9-substrate:   0.372
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.062
CYP3A4-inhibitor:   0.999 CYP3A4-substrate:   0.865
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.554
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  9.0 Half-life (T1/2):  0.767

ADMET: Toxicity

hERG Blockers:  0.066 hERG Blockers (10um):  0.18
Human Hepatotoxicity (H-HT):  0.96 Drug-induced Liver Injury (DILI):  0.954
AMES Toxicity:  0.899 Rat Oral Acute Toxicity:  0.437
Maximum Recommended Daily Dose:  0.544 Skin Sensitization:  0.993
Carcinogencity:  0.892 Eye Corrosion:  0.05
Eye Irritation:  0.917 Respiratory Toxicity:  0.822
Drug-induced Neurotoxicity:  0.508 Ototoxicity:  0.443
Hematotoxicity:  0.418 Drug-induced Nephrotoxicity:  0.84
Genotoxicity:  0.856 RPMI-8226 Immunitoxicity:  0.032
A549 Cytotoxicity:  0.023 Hek293 Cytotoxicity:  0.208
BCF:   0.932
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.613
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.904
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.47
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23557 Zanthoxylum ailanthoides Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[19128011]
NPO23557 Zanthoxylum ailanthoides Species Rutaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23557 Zanthoxylum ailanthoides Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO23557 Zanthoxylum ailanthoides Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO23557 Zanthoxylum ailanthoides Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 4.2 ug.mL-1 PMID[19128011]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 6.2 ug.mL-1 PMID[19128011]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC245650 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6471 Remote Similarity NPC145032
0.6471 Remote Similarity NPC307435
0.6471 Remote Similarity NPC304223
0.6471 Remote Similarity NPC54542
0.6286 Remote Similarity NPC267340
0.5833 Remote Similarity NPC243539
0.575 Remote Similarity NPC6795
0.5676 Remote Similarity NPC195986
0.5556 Remote Similarity NPC267692
0.5526 Remote Similarity NPC104138
0.5526 Remote Similarity NPC273023
0.5526 Remote Similarity NPC24216
0.5526 Remote Similarity NPC306420
0.5385 Remote Similarity NPC261158
0.5385 Remote Similarity NPC303672
0.5349 Remote Similarity NPC187315
0.5238 Remote Similarity NPC305288
0.5238 Remote Similarity NPC14326
0.5238 Remote Similarity NPC163912
0.5122 Remote Similarity NPC167759
0.5122 Remote Similarity NPC56028
0.5122 Remote Similarity NPC123669

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC245650 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data